BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6838187)

  • 1. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
    Schaad UB; Casey PA; Cooper DL
    Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a syrup formulation of amoxycillin-potassium clavulanate in children.
    Schaad UB; Casey PA; Ravenscroft AT
    J Antimicrob Chemother; 1986 Mar; 17(3):341-5. PubMed ID: 3700293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
    Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N
    Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
    Weber DJ; Tolkoff-Rubin NE; Rubin RH
    Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Shinozaki T; Meguro H; Fujii R; Mashiko Z; Okamoto Y; Arimasu O
    Jpn J Antibiot; 1985 Feb; 38(2):269-86. PubMed ID: 4009949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of obstetrics and gynecology].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1983 Mar; 36(3):481-6. PubMed ID: 6876360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K
    Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
    Boon RJ; Beale AS; Comber KR; Pierce CV; Sutherland R
    Antimicrob Agents Chemother; 1982 Sep; 22(3):369-75. PubMed ID: 7137980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Haruta T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I; Horiguchi S; Hatae T
    Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of hemodialysis on the pharmacokinetics of amoxicillin/clavulanic acid combination.
    Slaughter RL; Kohli R; Brass C
    Ther Drug Monit; 1984; 6(4):424-7. PubMed ID: 6393464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral augmentin: pharmacokinetics.
    Staniforth DH; Jackson D; Horton R; Davies B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):430-4. PubMed ID: 6490225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
    Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.